Annual ROA
-354.19%
-206.93%-140.52%
December 31, 2023
Summary
- As of February 8, 2025, CLRB annual return on assets is -354.19%, with the most recent change of -206.93% (-140.52%) on December 31, 2023.
- During the last 3 years, CLRB annual ROA has fallen by -328.46% (-1276.56%).
- CLRB annual ROA is now -1276.56% below its all-time high of -25.73%, reached on December 31, 2020.
Performance
CLRB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-164.74%
+35.27%+17.63%
September 30, 2024
Summary
- As of February 8, 2025, CLRB quarterly return on assets is -164.74%, with the most recent change of +35.27% (+17.63%) on September 30, 2024.
- Over the past year, CLRB quarterly ROA has increased by +146.47% (+47.06%).
- CLRB quarterly ROA is now -382.33% below its all-time high of 58.35%, reached on December 31, 2010.
Performance
CLRB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
CLRB ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -140.5% | +47.1% |
| 3 y3 years | -1276.6% | -283.9% |
| 5 y5 years | -302.8% | -76.7% |
CLRB ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -446.3% | at low | -210.7% | +47.1% |
| 5 y | 5-year | -1276.6% | at low | -283.9% | +47.1% |
| alltime | all time | -1276.6% | +17.3% | -382.3% | +100.0% |
Cellectar Biosciences ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -164.74%(-17.6%) |
| Jun 2024 | - | -200.01%(-33.3%) |
| Mar 2024 | - | -299.71%(-3.7%) |
| Dec 2023 | -354.19%(+140.5%) | -311.21%(+10.8%) |
| Sep 2023 | - | -280.96%(+22.9%) |
| Jun 2023 | - | -228.65%(+42.1%) |
| Mar 2023 | - | -160.92%(+25.0%) |
| Dec 2022 | -147.26%(+127.1%) | -128.73%(+34.8%) |
| Sep 2022 | - | -95.47%(+29.2%) |
| Jun 2022 | - | -73.88%(+22.8%) |
| Mar 2022 | - | -60.18%(+13.5%) |
| Dec 2021 | -64.84%(+152.0%) | -53.03%(+23.6%) |
| Sep 2021 | - | -42.91%(-1.9%) |
| Jun 2021 | - | -43.72%(-1.1%) |
| Mar 2021 | - | -44.21%(-18.1%) |
| Dec 2020 | -25.73%(-77.6%) | -53.96%(-40.5%) |
| Sep 2020 | - | -90.76%(-7.7%) |
| Jun 2020 | - | -98.28%(-5.1%) |
| Mar 2020 | - | -103.55%(+9.5%) |
| Dec 2019 | -115.04%(+30.8%) | -94.59%(+1.5%) |
| Sep 2019 | - | -93.21%(+13.1%) |
| Jun 2019 | - | -82.39%(-16.7%) |
| Mar 2019 | - | -98.89%(-4.5%) |
| Dec 2018 | -87.94%(-16.5%) | -103.52%(-6.1%) |
| Sep 2018 | - | -110.19%(-22.4%) |
| Jun 2018 | - | -141.94%(+12.6%) |
| Mar 2018 | - | -126.01%(+17.6%) |
| Dec 2017 | -105.37%(+161.3%) | -107.12%(+17.8%) |
| Sep 2017 | - | -90.92%(+9.7%) |
| Jun 2017 | - | -82.90%(+7.4%) |
| Mar 2017 | - | -77.17%(+29.8%) |
| Dec 2016 | -40.33%(-44.2%) | -59.47%(+90.2%) |
| Sep 2016 | - | -31.26%(+9.4%) |
| Jun 2016 | - | -28.58%(-14.9%) |
| Mar 2016 | - | -33.60%(-48.7%) |
| Dec 2015 | -72.34%(+20.6%) | -65.52%(-34.1%) |
| Sep 2015 | - | -99.49%(+58.9%) |
| Jun 2015 | - | -62.60%(-3.0%) |
| Mar 2015 | - | -64.52%(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -60.00%(-62.1%) | -74.78%(-21.2%) |
| Sep 2014 | - | -94.93%(-29.9%) |
| Jun 2014 | - | -135.47%(+20.8%) |
| Mar 2014 | - | -112.17%(+11.6%) |
| Dec 2013 | -158.19%(+106.4%) | -100.53%(+33.0%) |
| Sep 2013 | - | -75.61%(-6.1%) |
| Jun 2013 | - | -80.55%(-2.2%) |
| Mar 2013 | - | -82.40%(-0.8%) |
| Dec 2012 | -76.64%(+8.9%) | -83.06%(+0.0%) |
| Sep 2012 | - | -83.04%(-6.6%) |
| Jun 2012 | - | -88.95%(-12.7%) |
| Mar 2012 | - | -101.93%(-7.1%) |
| Dec 2011 | -70.39%(-25.9%) | -109.75%(-1.3%) |
| Sep 2011 | - | -111.19%(+5.0%) |
| Jun 2011 | - | -105.92%(-8.8%) |
| Mar 2011 | - | -116.19%(-299.1%) |
| Dec 2010 | -94.96%(-77.8%) | 58.35%(-132.2%) |
| Sep 2010 | - | -181.06%(-7.7%) |
| Jun 2010 | - | -196.07%(-15.6%) |
| Mar 2010 | - | -232.40%(-41.2%) |
| Dec 2009 | -428.42%(+63.7%) | -395.20%(+62.2%) |
| Sep 2009 | - | -243.59%(+0.8%) |
| Jun 2009 | - | -241.67%(+10.5%) |
| Mar 2009 | - | -218.65%(-21.6%) |
| Dec 2008 | -261.68%(+54.1%) | -278.78%(+16.9%) |
| Sep 2008 | - | -238.49%(+15.3%) |
| Jun 2008 | - | -206.80%(+8.5%) |
| Mar 2008 | - | -190.63%(+34.3%) |
| Dec 2007 | -169.83%(+72.8%) | -141.96%(+30.5%) |
| Sep 2007 | - | -108.80%(+31.6%) |
| Jun 2007 | - | -82.69%(+25.0%) |
| Mar 2007 | - | -66.16%(+4.9%) |
| Dec 2006 | -98.28%(+59.0%) | -63.07%(+18.7%) |
| Sep 2006 | - | -53.13%(+34.1%) |
| Jun 2006 | - | -39.63%(-24.3%) |
| Mar 2006 | - | -52.33%(-45.8%) |
| Dec 2005 | -61.83% | -96.51%(+5.7%) |
| Sep 2005 | - | -91.31%(-33.6%) |
| Jun 2005 | - | -137.53%(-100.0%) |
| Mar 2005 | - | -410.70 K% |
FAQ
- What is Cellectar Biosciences annual return on assets?
- What is the all time high annual ROA for Cellectar Biosciences?
- What is Cellectar Biosciences annual ROA year-on-year change?
- What is Cellectar Biosciences quarterly return on assets?
- What is the all time high quarterly ROA for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly ROA year-on-year change?
What is Cellectar Biosciences annual return on assets?
The current annual ROA of CLRB is -354.19%
What is the all time high annual ROA for Cellectar Biosciences?
Cellectar Biosciences all-time high annual return on assets is -25.73%
What is Cellectar Biosciences annual ROA year-on-year change?
Over the past year, CLRB annual return on assets has changed by -206.93% (-140.52%)
What is Cellectar Biosciences quarterly return on assets?
The current quarterly ROA of CLRB is -164.74%
What is the all time high quarterly ROA for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly return on assets is 58.35%
What is Cellectar Biosciences quarterly ROA year-on-year change?
Over the past year, CLRB quarterly return on assets has changed by +146.47% (+47.06%)